EA201070175A1 - Фармацевтическая композиция контролируемого высвобождения, содержащая толперизона гидрохлорид - Google Patents

Фармацевтическая композиция контролируемого высвобождения, содержащая толперизона гидрохлорид

Info

Publication number
EA201070175A1
EA201070175A1 EA201070175A EA201070175A EA201070175A1 EA 201070175 A1 EA201070175 A1 EA 201070175A1 EA 201070175 A EA201070175 A EA 201070175A EA 201070175 A EA201070175 A EA 201070175A EA 201070175 A1 EA201070175 A1 EA 201070175A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical composition
hydrochloride
tolperizon
controlled voltage
voltage containing
Prior art date
Application number
EA201070175A
Other languages
English (en)
Other versions
EA018885B1 (ru
Inventor
Иштван Анталь
Дороттья Киш
Габор Оргован
Бернадетт Штиедль
Романа Зелько
Имре Клебович
Бела Ноцаль
Original Assignee
Рихтер Гедеон Нирт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рихтер Гедеон Нирт. filed Critical Рихтер Гедеон Нирт.
Publication of EA201070175A1 publication Critical patent/EA201070175A1/ru
Publication of EA018885B1 publication Critical patent/EA018885B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к фармацевтическим композициям, содержащим толперизона гидрохлорид, с контролируемым высвобождением активного агента и к способу их получения. Фармацевтическая композиция контролируемого высвобождения по изобретению содержит сложные гранулированные ядра, образованные природным анионным полимером и липофильным наполнителем, гидрофильный матрицеобразующий наполнитель, который окружает ядра, и другие фармацевтически приемлемые наполнители.
EA201070175A 2007-07-23 2008-07-22 Фармацевтическая композиция контролируемого высвобождения, содержащая толперизона гидрохлорид EA018885B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0700485A HUP0700485A3 (en) 2007-07-23 2007-07-23 Pharmaceutical composition with controlled release containing tolperisone
PCT/HU2008/000086 WO2009013552A1 (en) 2007-07-23 2008-07-22 Controlled release pharmaceutical composition of tolperison hydrochloride

Publications (2)

Publication Number Publication Date
EA201070175A1 true EA201070175A1 (ru) 2010-08-30
EA018885B1 EA018885B1 (ru) 2013-11-29

Family

ID=89987649

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201070175A EA018885B1 (ru) 2007-07-23 2008-07-22 Фармацевтическая композиция контролируемого высвобождения, содержащая толперизона гидрохлорид

Country Status (5)

Country Link
EP (1) EP2175839B1 (ru)
EA (1) EA018885B1 (ru)
HU (1) HUP0700485A3 (ru)
UA (1) UA100244C2 (ru)
WO (1) WO2009013552A1 (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT505225A1 (de) 2007-04-26 2008-11-15 Sanochemia Pharmazeutika Ag 0erfahren zur herstellung von hoch reinem 2,4'-dimethyl-3-piperidino-propiophenon (tolperison), dieses enthaltende pharmazeutische zusammensetzungen, sowie tolperison enthaltende wirkstoffformulierungen
US20100249423A1 (en) 2009-03-09 2010-09-30 Sanochemia Pharmazeutika Ag Tolperisone controlled release tablet
EA201171109A1 (ru) * 2009-03-09 2012-03-30 Динеш Шантилал Пател Новая композиция замедленного высвобождения соединений, выбранных из класса миорелаксантов центрального действия

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154918A (en) * 1974-10-08 1976-05-14 Nippon Kayaku Kk Jozaino seizoho
AT409083B (de) * 1999-04-01 2002-05-27 Sanochemia Pharmazeutika Ag Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
AT500144A1 (de) 2004-03-05 2005-11-15 Sanochemia Pharmazeutika Ag Tolperison enthaltende, pharmazeutische zubereitung mit steuerbarer wirkstofffreisetzung zur oralen verabreichung
FR2868281B1 (fr) 2004-03-30 2023-06-23 Commissariat Energie Atomique Procede de determination des mouvements d'une personne.
US20070009564A1 (en) * 2005-06-22 2007-01-11 Mcclain James B Drug/polymer composite materials and methods of making the same
MX2008012299A (es) * 2006-03-31 2008-11-18 Rubicon Res Private Ltd Tabletas de desintegracion oral.

Also Published As

Publication number Publication date
EP2175839B1 (en) 2012-12-19
EP2175839A1 (en) 2010-04-21
HUP0700485A3 (en) 2010-01-28
HU0700485D0 (en) 2007-09-28
EA018885B1 (ru) 2013-11-29
WO2009013552A1 (en) 2009-01-29
UA100244C2 (ru) 2012-12-10
HUP0700485A2 (en) 2009-04-28

Similar Documents

Publication Publication Date Title
CO6670598A2 (es) Forma de dosificación resistente a alteración que comprende un polímero aniónico
MX2011012122A (es) Derivados de tiofeno.
DOP2013000172A (es) Composicion farmaceutica
UY32599A (es) Formulación oral sólida de abt-263
WO2010146179A3 (en) Solid pharmaceutical composition comprising rivaroxaban
AR089578A1 (es) Composiciones, metodos para tratar el virus de la hepatitis c y proceso de preparacion
EA201690102A1 (ru) Фармацевтическая композиция, содержащая диметилфумарат, для введения в низкой суточной дозе
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
UA110013C2 (uk) Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів
EA201071218A1 (ru) Улучшенные композиции для активных фармацевтических компонентов с плохой проницаемостью
CO6400186A2 (es) Tabletas de acetato de ulipristal
PE20091949A1 (es) Formulacion farmaceutica solida con liberacion retardada
CO6251360A2 (es) Bromhidrato de bupropion y aplicaciones terapeuticas
BR112012021681A8 (pt) Rifaximina em pó, processo para preparação da mesma e composições de liberação controladas contendo a referida rifaximina útil para obtenção de um efeito de longa duração.
EA201170512A1 (ru) Композиция для перорального введения
BR112012026596A2 (pt) método para preparar composições farmacêuticas pretendidas para administração oral compreendendo um ou mais ingredientes ativos e as composições que compreendem as mesmas
UY32749A (es) Composiciones de dosis fija farmaceuticas solidas que comprenden irbesartan y amlodipina, su preparacion y su aplicacion terapeutica
TN2015000135A1 (en) Modified release formulations for oprozomib
CO6640318A2 (es) Formas de dosificación oral de bendamustina
WO2011064558A3 (en) Pharmaceutical composition
EA201070175A1 (ru) Фармацевтическая композиция контролируемого высвобождения, содержащая толперизона гидрохлорид
UY30126A1 (es) Una nueva sal farmaceuticamente aceptable de 2-hidroxi-3-(5-(morfolin-4-ilmetil)-piridin-2-l)1h-indol-5-carbonitrilo, procedimientos para su preparacion, composiciones que la contienen yaplicaciones
WO2010079433A3 (en) Pharmaceutical composition comprising melogliptin
AR048970A1 (es) Formulacion farmaceutica solida
AR060869A1 (es) Composicion farmaceutica solida de gabapentina

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU